Launch
Website- Bupa Platinum consultant
- Fee assured
- Awaiting verification
- Open Referral network
Specialises in
- Skin
- Urology
Offers
- Face-to-face consultations
- Video and telephone consultations
- Home chemotherapy
About me
Dr. Amarnath Challapalli is a Consultant Clinical Oncologist at Bristol Cancer Institute, University Hospitals Bristol NHS Foundation Trust specialising in the management of urological cancers and non-melanomatous skin cancer with radiotherapy, chemotherapy and immunotherapy. He chairs the clinical governance committee at the Bristol Cancer Institute and is a member of the Medicines advisory group (MAG). He organises and lectures in the skin cancer study day for the Royal College of Radiologists and is a faculty member on other courses for the college. He is also a panel member of Mirrors in Medicine, an International Case-based professional development platform. This panel pinpoints important clinical topics and provide a concise summary of evidence from clinical studies and guidelines. He also lectures on various topics both at regional and national level.
Dr. Challapalli undertook his medical and postgraduate training in clinical oncology in India and in the UK, achieving Fellowship of the Royal College of Radiologists. He subsequently completed a PhD at Imperial College, London in January 2014. His research focused on the translation of novel PET tracers looking at cell proliferation, apoptosis and choline metabolism into clinical studies to look at early response assessment to treatment. He is the UK Chief Investigator for the adjuvant Cemiplimab trial in high risk squamous cell carcinoma and a Co-Chief Investigator of the national multicentre ACE trial. His work has been published in peer-reviewed journals and presented at national and international meetings.
Areas of interest
prostate cancer; bladder cancer; renal cancer; penile cancer; testicular cancer radiotherapy; nonmelanoma skin cancers.
Medical secretaries
- Becky Gordon
- Genesis Care 300 Park Avenue Aztec West Almondsbury Bristol BS32 4SY
- 01454 456542
- 01454 456523
- rebecca.gordon@genesiscare.co.uk
Information for healthcare professionals (Bupa patients only, last 12 months)
-
X0003
Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 1-21 days - (5-50)
-
AA843
Clinical supervision and planning for delivery of chemotherapy cycle, remote or in the member's home 1-21 days - (1-5)
-
X6930
Clinical supervision of the planning of a course of complex radiotherapy - (1-5)
-
X0008
Clinical supervision of external beam radiotherapy, for 16 or up to and including 30 fractions - (1-5)
-
X0007
Clinical supervision of external beam radiotherapy, up to and including 15 fractions or part thereof - (1-5)